Process for preparing chiral dipeptidyl peptidase-IV inhibitors

US9862725B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9862725-B2
Application numberUS-201515325100-A
CountryUS
Kind codeB2
Filing dateJul 16, 2015
Priority dateJul 21, 2014
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for preparing a compound of structural Formula Ia: comprising Boc deprotection with TFA of, reductive amination of:

First claim

Opening claim text (preview).

What is claimed is: 1. A process for preparing a compound of structural Formula Ia: comprising reacting a compound of Formula 1 with TFA: to produce a TFA salt of a compound of Formula 1a: and reacting the TFA salt of a compound of Formula 1a with a compound of Formula 7 under reductive amination conditions: to produce the compound of Formula Ia. 2. The process of claim 1 , wherein the process is done as a through process. 3. The process of claim 1 , further comprising the step of crystallizing Formula Ia. 4. The process of claim 1 , wherein the amount of TFA is 1-5 volumes. 5. The process of claim 1 , wherein the amount of TFA is 3 volumes. 6. A process of preparing a compound of structural Formula I: comprising reacting a compound of Formula 1 with TFA: to produce a TFA salt of a compound of Formula 1a: reacting the TFA salt of a compound of Formula 1a with a compound of Formula 7 under reductive amination conditions: to produce a compound of Formula Ia; and removing the Boc group of Formula Ia to produce the compound of Formula I. 7. The process of claim 6 , wherein the compound of Formula Ia is crystallized prior to removing the Boc protecting group.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Oxygen atoms, e.g. delta-lactones · CPC title

  • C07D487/04Primary

    Ortho-condensed systems · CPC title

  • condensed with heterocyclic ring systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9862725B2 cover?
A process for preparing a compound of structural Formula Ia: comprising Boc deprotection with TFA of, reductive amination of:
Who is the assignee on this patent?
Merck Sharp & Dohme
What technology area does this patent fall under?
Primary CPC classification C07D487/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).